Worldly Partners Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$340K Hold
115,798
– – 0.33% 3
2026
Q2
$520K Sell
115,798
-1
-0% -$7 0.42% 3
2026
Q1
$1.22M Hold
115,799
– – 1.03% 3
2025
Q4
$1.33M Hold
115,799
– – 0.99% 3
2025
Q3
$2.81M Hold
115,799
– – 1.68% 3
2025
Q2
$1.9M Hold
115,799
– – 1.04% 3
2025
Q1
$2.11M Hold
115,799
– – 1.19% 3
2024
Q4
$4.3M Hold
115,799
– – 2.25% 3
2024
Q3
$3.71M Hold
115,799
– – 1.76% 3
2024
Q2
$9.5M Hold
115,799
– – 5.1% 3
2024
Q1
$16.8M Hold
115,799
– – 7.91% 3
2023
Q4
$10.7M Buy
115,799
+16,111
+16% +$1.64M 5.92% 3
2023
Q3
$16.4M Buy
99,688
+1,859
+2% +$242K 10.5% 3
2023
Q2
$6.18M Hold
97,829
– – 3.54% 3
2023
Q1
$3.32M Hold
97,829
– – 2.1% 4
2022
Q4
$5.65M Hold
97,829
– – 4.4% 3

Other funds holding CDLX

Worldly Partners Management's CDLX Position: Q3 2026 in Review

Worldly Partners Management held its Cardlytics (CDLX) position steady in Q3 2026 at 115,798 shares worth $340K. The position accounts for 0.33% of the portfolio, ranked #3.

Worldly Partners Management first reported a position in CDLX in Q4 2022 and has held it in 16 quarters since. The position peaked at $16.8M in Q1 2024. 40 funds tracked by Wall St. Rank hold CDLX as of Q3 2026.

  • Worldly Partners Management held 115,798 shares of Cardlytics worth $340K as of Q3 2026.
  • Worldly Partners Management left its Cardlytics share count unchanged in Q3 2026.
  • Cardlytics made up 0.33% of Worldly Partners Management's portfolio in Q3 2026, its #3 holding.
  • Worldly Partners Management first reported a position in Cardlytics in Q4 2022 and has held it in 16 quarters since.
  • Worldly Partners Management's Cardlytics position peaked at $16.8M in Q1 2024.
  • 40 funds tracked by Wall St. Rank held Cardlytics as of Q3 2026.

Based on Worldly Partners Management's 13F filing for Q3 2026, filed 17 Nov 2026.